Updates
** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%
** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay
** White House officials say government will give drugmakers price targets in next 30 days
** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5%
** "While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view," brokerage UBS says
** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。